Multiple Myeloma, Cancer News Articles

Multiple Myeloma News

MULTIPLE MYELOMA ADVISOR

Multiple Myeloma News

Xpovio Multiple Myeloma Indication Expanded

The approval was based on data from the BOSTON trial that assessed Xpovio in combination with bortezomib and dexamethasone in 402 adults with relapsed or refractory multiple myeloma who had received 1 to 3 prior therapies.
Next post in Multiple Myeloma News